Active Laminin Alpha 2 (LAMa2) Mus musculus (Mouse) Active protein

LAM-A2; LAMM; Merosin; Congenital Muscular Dystrophy; Laminin M chain; Merosin heavy chain

No quotes Distributors
Overview
Properties
  • Buffer FormulationPBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
  • Traits Freeze-dried powder, Purity > 90%
  • Isoelectric Point6.8
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Active Laminin Alpha 2 (LAMa2) Packages (Simulation)
  • Active Laminin Alpha 2 (LAMa2) Packages (Simulation)
  • APC074Mu01.jpg Figure. SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Activity test

Laminin Alpha 2 (LAMa2) is a large‑sized alpha‑chain subunit of laminin, a major structural glycoprotein residing in basement membranes across various tissues. It is predominantly expressed in skeletal muscle, peripheral nerves and placenta, assembling with other laminin subunits to form heterotrimeric laminin complexes that maintain basement‑membrane integrity. This subunit mediates cell‑matrix adhesion, stabilizes muscle cell membrane architecture, supports Schwann cell anchoring around nerve axons, and modulates cell proliferation, differentiation and tissue regeneration. Loss or mutation of LAMa2 frequently causes congenital muscular dystrophy and peripheral nerve dysmyelination, as impaired basement membrane assembly disrupts tissue mechanical support and intercellular signal transmission. Its expression level is finely tuned during development and tissue injury repair. LAMa2 associates with LAMC2 to constitute partial heterotrimeric laminin assemblies for basement membrane construction. To detect the activity of recombinant mouse LAMa2, a functional ELISA assay was performed to evaluate the interaction between recombinant mouse LAMa2 and recombinant human LAMC2. Briefly, biotin-linked LAMa2 were diluted serially in PBS, with 0.01% BSA (pH 7.4). Duplicate samples of 100µl were then transferred to LAMC2-coated microtiter wells and incubated for 1h at 37℃. Wells were washed with PBST 3 times and incubation with Streptavidin-HRP for 30min, then wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50µl stop solution to the wells and read at 450nm immediately. The binding activity of mouse LAMa2 and human LAMC2 was shown in Figure 1, the EC50 for this effect is 0.135 µg/mL.

Usage

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

Storage

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

Stability

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Recommend products